BioNxt Solutions Settles Debt Through Share Issuance

BioNxt Solutions Inc. has completed the issuance of 6,008,883 common shares to settle $2,704,000 in debt. The settlement pertains to amounts owed to arm's length creditors, derived from $2,600,000 principal and $104,000 accrued interest on 8% convertible debentures from December 2022. The shares were valued at $0.45 each. Additionally, 300,444 shares were issued to Canaccord Genuity Corp. at $0.63 per share for assisting with the settlement. All shares are subject to a four-month statutory hold under Canadian securities law.